Top Warren Buffett Companies To Buy For 2014

From the impact of Obamacare to cutting-edge research, biotech buyouts to FDA decisions, The Motley Fool's health-care team sits down each week�to discuss the most fascinating developments in health care, and their implications for long-term investors. In this week's edition, the team talks about a potentially landmark Supreme Court ruling, the impact of President Obama's budget on health-care stocks, the next wave of innovation for the pharma industry, and why investors need to pay attention to a small research company from upstate New York.

In the following segment, health-care analyst David Williamson dives into the legal battle between Myriad Genetics and those who question its ability to patent human genes. The Supreme Court is hearing opening arguments, with a decision expected later this summer.

Watch and discover how far the impact of this verdict could reach.

What macro trend was Warren Buffett referring to when he said "this is the tapeworm that's eating at American competitiveness"? Find out in our free report: "What's Really Eating at America's Competitiveness." You'll also discover an idea to profit as companies work to eradicate this efficiency-sucking tapeworm. Just click here for free, immediate access.

Best Media Companies To Own For 2015: CombiMatrix Corporation(CBMX)

CombiMatrix Corporation, a molecular diagnostics company, operates primarily in the fields of genetic analysis and molecular diagnostics in the United States. The company, through its wholly owned subsidiary, CombiMatrix Diagnostics, operates a diagnostics reference laboratory that provides DNA-based clinical diagnostic testing services to physicians, hospitals, and other laboratories in two primary areas, including prenatal and postnatal developmental disorders, and oncology. It offers a suite of developmental disorder array tests on the prenatal and postnatal application of array-comparative genomic hybridization in diagnosing genomic syndromes associated with developmental delays, autism spectrum disorders, dysmorphic features, and/or birth defects. The company also provides DNAarray?Heme Profile test to address various common hematological malignancies, including chronic lymphocytic leukemia; DNAarray?HER2 PRO test for breast cancer; and DNAarray?Tumor Profile test for the analysis of solid tumors, including breast, colon, lung, prostate, and brain tumors. In addition, it focuses on developing a series of drug compounds to address various oncology-related diseases. CombiMatrix Corporation was founded in 1995 and is based in Irvine, California.

Advisors' Opinion:

• [By Roberto Pedone]

  One stock that's starting to trend within range of triggering a near-term breakout trade is CombiMatrix (CBMX), which operates a diagnostics reference laboratory that provides DNA-based clinical diagnostic testing services to physicians, hospitals, clinics and other laboratories in the areas of prenatal and postnatal development disorders, and hematology/oncology genomics. This stock hasn't done much over the last three months, with shares up by just 1.4%.

  If you take a look at the chart for CombiMatrix, you'll notice that this stock has been uptrending over the last few weeks, with shares moving higher from its low of $2.14 to its recent high of $2.90 a share. During that move, shares of CBMX have been making mostly higher lows and higher highs, which is bullish technical price action. That uptrend has now pushed shares of CBMX within range of triggering a near-term breakout trade.

  Traders should now look for long-biased trades in CBMX if it manages to break out above some near-term overhead resistance levels at $2.90 to $2.92 a share, and then once it clears its 200-day moving average at $2.96 to more near-term overhead resistance at $3.20 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 823,656 shares. If that breakout triggers soon, then CBMX will set up to re-test or possibly take out its next major overhead resistance levels at $3.70 to $4.44 a share.

  Traders can look to buy CBMX off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average at $2.57 a share or just below more support at $2.20 to $2.14 a share. One can also buy CBMX off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Warren Buffett Companies To Buy For 2014: NanoTech Entertainment Inc (NTEK)

NanoTech Entertainment, Inc. (NanoTech), formerly Aldar Group, Inc., is a provider of gaming technology for the coin-op arcade, casino gaming and consumer gaming markets. The Company operates as a manufacturer, developing technology and games, and then licensing them to third parties for manufacturing and distribution. As of June 30, 2009, the Company�� products included MultiPin, Xtreme Rally Racing, NanoNET Online System, Pinball Wizard, Mot-Ion Adapter, Opti-Gun Adapter and Retr-IO Adapter. In April 2009, the Company acquired NanoTech Entertainment, Inc. In July 2013, NanoTech Entertainment Inc completed the acquisition of Clear Memories, Inc. of Napa California. Effective August 9, 2013, NanoTech Entertainment Inc acquired Worldwide Global Entertainment, a developer of prepackaged software.

The Company�� physics engine and motion sensors allow MultiPin to accurately recreate the experience of a mechanical pinball machine, while providing players with a variety of classic and modern pinball games to choose from. Xtreme Rally Racing is a driving machine that features three modes of game play: Xtreme Off-Road-Race Head to Head against other players and the computer to checkpoints while driving anywhere on the map with no preset course; Timed Rally Stages-Classic Rally Racing on real world courses. Players will be able to race in five different countries on real world rally courses, and Xtreme Stadium Racing-Custom Stadiums designed for Xtreme racing, including a figure eight multi-lap course with huge jumps. NanoNET Online System is remote operator control of machines, including diagnostics, accounting reports, and automatic software updates and enhancements downloaded over the net.

The Company has created the input device designed to give the pinball players a way to experience real pinball controls on their personal computer. Based on the technology developed for the MultiPin product it has built a controller that lets people play pinball using traditional controls and! the ability to shake and nudge the table. The Mot-Ion adapter is a universal serial bus (USB) adapter that allows do it yourself Pinball enthusiasts to build their own cabinet using real pinball controls providing analog inputs for nudging and bumping. The OptiGun adapter is a USB adapter that allows players to connect Arcade Light Guns to any USB based system. The Retr-IO adapters provide a standard JAMMA interface for USB based systems.

Advisors' Opinion:

• [By James E. Brumley]

  Looking for a couple of near-term trades that have a decent shot at rallying even if the broad market feels like it might pull back? Then take a look at Liquidmetal Technologies Inc. (OTCBB:LQMT) and NanoTech Entertainment, Inc. (OTCMKTS:NTEK). Although both LQMT and NTEK will be dismissed by some traders simply because they're OTC-listed stocks, for those traders willing to look past the exchange and appreciate the opportunity, the risk-versus-reward ratio is actually quite compelling.

• [By Bryan Murphy]

  Call them hunches (because that's all they are), but now would be a great time to get out of a NanoTech Entertainment, Inc. (OTCMKTS:NTEK) position and/or get into an ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). NTEK looks like its reached its maximum potential - for the time being - while ACAD looks like it's ready to start rolling higher again.

Top Warren Buffett Companies To Buy For 2014: Zinco Do Brasil Inc (ZNBR)

Zinco do Brasil Inc., formerly TurkPower Corporation, incorporated on November 4, 2004, has been a Turkish-American consulting and service operations firm and junior mining company. TurkPower offered its domestic and international clients consulting services and plans to act as a full service operator for wind, hydro, solar, coal and geothermal energy parks in Turkey.

In November 2011, the Company ceased all operations in Turkey. During the fiscal year ended May 31, 2012 (fiscal 2012) the Company impaired its entire mining company investment.

Advisors' Opinion:

• [By Peter Graham]

  Small cap mining stocks Discovery Minerals Ltd (OTCMKTS: DSCR), Zinco Do Brasil Inc (OTCMKTS: ZNBR) and Amalgamated Gold and Silver Inc (OTCMKTS: BCHS) have been getting some extra attention lately as one stock surged last Friday while the other two are or have been in the past, the subject of paid promotions. It goes without saying though that small cap mining stocks tend to be riskier than your average stock. But do these three small cap mining stocks have what it takes to produce a mother lode for investors? Here is a deeper dig into all three:

Top Warren Buffett Companies To Buy For 2014: Neutra Corp (NTRR)

Neutra Corp. incorporated on January 11, 2011, is a development-stage company. The Company�� business and registered office is located in Sarasota, Florida. The Company�� intended private label products consists of aging, cognitive support, antioxidants/flavonoids, circulatory support, detoxification support, endocrine support, essential fatty acids, gastrointestinal support, immune support, men�� health, minerals, mood/sleep support, multiples, musculoskeletal support, neurological support, proteins/amino acids, vitamins, women�� health and veterinary products. The Company�� product focuses to research and development in a range of areas, such as weight-loss, detox, men�� health, acid-alkali pH balance, anti-aging, sleep disorders, autism, pain management with the use of medical cannabis products, and air space sanitation derived by nutraceutical technology.

The Company focuses to market and sell nutraceutical supplement products to health practitioners. It focuses direct marketing and sales towards Members of the American Association for Health Freedom (American Association for Health Freedom has merged with Alliance for Natural Health) www.anh-usa.org; American Association of Naturopathic Physicians, www.naturopathic.org; American Association of Oriental Medicine, www.aaom.org, and American College for Advancement in Medicine, www.acamnet.org. It also focuses direct marketing and sales towards American Holistic Medical Association, www.holisticmedicine.org; American Dietetic Association, www.eatright.org, and American Herbalist Guild, www.americanherbalistsguild.com.

The Company competes with Thone Research, The Vitamin Company, Nutraceutical International Corporation, Protocol For Life, Medagenics and Standard Process.

Advisors' Opinion:

• [By CRWE]

  Today, NTRR surged (+19.45%) up +0.068 at $.420 with 22,114 shares in play thus far (ref. google finance Delayed: 11:17AM EDT July 11, 2013).

  As Neutra Corp. works to deliver new innovations to the U.S. medical marijuana industry, the market for those innovations continues to grow. Last week, lawmakers passed a bill to make New Hampshire the 19th state to approve medical marijuana (MMJ) prescriptions for patients with chronic or terminal illnesses.

  The legislation will make New Hampshire the 19th state to legalize MMJ, in addition to the District of Columbia. Five more states have legislation pending to legalize prescriptions, according to ProCon.org.

• [By CRWE]

  Today, NTRR has shed (-5.26%) down -0.020 at $.360 with 14,150 shares in play thus far (ref. google finance Delayed: 10:46AM EDT July 3, 2013), but don�� let this get you down.

  Neutra Corp. through a key new partnership with an innovative cannabis delivery systems provider in the medical marijuana industry, is poised to make an impact in the lucrative $52 billion pain management market.

  With partner Field of View Technologies, LLC, exploring new technology in cannabis delivery systems, NTRR is ready to provide much-needed smokeless delivery systems to those most in need: patients forced to live with debilitating pain.

  A recent study by Columbia University found that smoke-free cannabinoid medication was effective in treating pain. Smokeless delivery systems can be administered orally, by injection or topically, giving the patient the choice of treatment method as NTRR and Field of View set the pace in the potentially lucrative pain management market.

Top Warren Buffett Companies To Buy For 2014: AMN Healthcare Services Inc(AHS)

AMN Healthcare Services, Inc. provides healthcare staffing and clinical workforce management solutions in the United States. The company?s Nurse and Allied Healthcare Staffing segment provides staffing solutions for hospitals and other healthcare facilities, including medical, surgical, specialty, licensed practical or vocational, and advanced practice nurses, as well as surgical technologists and dialysis technicians. This segment also offers allied health professionals under the Med Travelers, Club Staffing, and Rx Pro Health brand names to acute-care hospitals and other healthcare facilities, such as skilled nursing facilities, rehabilitation clinics, and retail and mail-order pharmacies. These allied health professionals include physical, surgical, respiratory, and occupational therapists, as well as medical and radiology technologists, speech pathologists, rehabilitation assistants, pharmacists, and pharmacy technicians. Its Locum Tenens Staffing segment places physic ians of various specialties, certified registered nurse anesthetists, nurse practitioners, and dentists on a temporary basis as independent contractors with various healthcare organizations, including hospitals, medical groups, occupational medical clinics, individual practitioners, networks, psychiatric facilities, government institutions, and managed care entities. The company?s Physician Permanent Placement Services segment provides permanent physician placement services to hospitals, healthcare facilities, and physician practice groups under the Merritt Hawkins and Kendall & Davis brand names. This segment also offers specialty offerings, including internal medicines, family practices, and surgeries. Its Home Healthcare Services segment provide home healthcare services to individuals with acute-care illness, long-term chronic health conditions, permanent disabilities, terminal illnesses, and post-procedural needs. The company was founded in 1985 and is headquartered in S an Diego, California.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on AMN Healthcare Services (NYSE: AHS  ) , whose recent revenue and earnings are plotted below.

• [By Sean Williams]

  What: Shares of AMN Healthcare Services (NYSE: AHS  ) , a health care staffing solutions company, jumped as much as 11% after reporting its third-quarter earnings results.

Top Warren Buffett Companies To Buy For 2014: Cadus Corp (KDUS)

Cadus Corporation (Cadus), incorporated in January 23, 1992, has a wholly owned subsidiary, Cadus Technologies, Inc. (the Subsidiary), which holds all patents, patent applications, know how, licenses and drug discovery technologies of the Company. The Company maintains all its strains, as well as a biological database that catalogues its collection of cells, cell lines, yeast strains and genetic engineering tools. This database has approximately 30,000 entries, which include the phenotype and the genotype of the cell or yeast strain and its storage site. As of December 31, 2011, the Company had no internal or external drug discovery operations.

Yeast

The Company has developed technologies based on yeast that are useful in identifying drug discovery candidates targeted at G Protein-coupled receptors. Yeast is a single-celled microorganism that is used to make bread, beer and wine. Both yeast and human cells consist of a membrane, an intracellular region and a nucleus containing genes. The genes in yeast express proteins, including cell-surface receptors, such as G Protein-coupled receptors and signaling molecules, such as protein kinases, that are similar to human proteins.

Hybrid Yeast Cells

The Company developed a technology to insert human genes into yeast cells to create hybrid yeast cells. Its scientists created hybrid yeast cells by replacing yeast G Protein-coupled receptor genes and certain signaling molecules with their human equivalents. As a result, these hybrid yeast cells express a human G Protein-coupled receptor and a portion of its signaling pathway. These hybrid yeast cells can be used to identify those compounds that act as agonists or antagonists to that receptor or a molecule that is in its signaling pathway. The Company designed and developed more than 25 thousand genetically different yeast strains that can be used to build hybrid yeast cells (the Yeast System).

The Company competes with Glaxo Smith Kline, Plc.

Advisors' Opinion:

• [By Geoff Gannon] cash producing business like ADDvantage (AEY) that happens to be overcapitalized. I'd much rather own a business with real earnings rather than wait for something to happen with a pile of cash.

  My question is this: How cheap is cheap enough? Clearly (to me), George Risk (RSKIA) is cheap at or even just above book value. It's a darn good business so I'm getting high quality assets and earnings power. That gets less clear when looking at lower quality businesses.

  For example:

  Solitron (SODI) sells at 74% of NCAV, has decent z- and f-scores, a FCF margin of 5.3% and an ROA of 12%.

Top Warren Buffett Companies To Buy For 2014: Aberdeen Emerging Markets Smaller Company Opportunities Fund Inc (ETF)

Aberdeen Emerging Markets Smaller Company Opportunities Fund Inc (the Fund), formerly Aberdeen Emerging Markets Telecommunications and Infrastructure Fund, Inc., non-diversified management investment company. The Fund�� principal investment objective is to seek long-term capital appreciation. Under normal market conditions, at least 80% of the Fund�� net assets, plus any borrowings for investment purposes, are invested in equity and debt securities of emerging markets telecommunications companies and of infrastructure companies. In addition, under normal market conditions, at least 20% (but not more than 24.9% at the time of purchase) of the Fund�� net assets will be invested in equity and debt securities of companies in the infrastructure industry. Aberdeen Asset Managers Limited (AAML) serves as the Fund�� investment adviser with respect to all investments. Advisors' Opinion:

• [By Rich Bieglmeier]

  [Related -SPDR Gold Trust (ETF) (GLD): What Will Move Gold As Ukraine Crisis Eases?]

  Back to atomic Number 79; iStock thought a 3-T review of gold might be timely as many investors might be wondering if the recent vertical drop is a buying opportunity or if it is best to stand on the sidelines.